These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9914744)

  • 21. Why did the FDA approve these advertisements?
    Oaks D
    PLoS Med; 2006 Feb; 3(2):e117; author reply e116. PubMed ID: 16492081
    [No Abstract]   [Full Text] [Related]  

  • 22. An investigation into the pharmaceutical advertising in Iranian medical journals.
    Yousefi N; Sharif Z; Chahian F; Mombeini T; Peiravian F
    J Pharm Policy Pract; 2022 Mar; 15(1):18. PubMed ID: 35255995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL; Katz KA
    Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Who does need Cipralex and why?].
    Bendz H
    Lakartidningen; 2002 May; 99(20):2320-1. PubMed ID: 12082954
    [No Abstract]   [Full Text] [Related]  

  • 25. Quality of claims, references and the presentation of risk results in medical journal advertising: a comparative study in Australia, Malaysia and the United States.
    Othman N; Vitry AI; Roughead EE
    BMC Public Health; 2010 May; 10():294. PubMed ID: 20509953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in the volume of pharmaceutical advertisements between print general medical journals.
    Gettings J; O'Neill B; Chokshi DA; Colbert JA; Gill P; Lebovic G; Lexchin J; Persaud N
    PLoS One; 2014; 9(1):e84790. PubMed ID: 24416286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug advertisements in two dermatology journals: a critical comparison of IJDVL and JAAD.
    Gahalaut P; Chauhan S; Mishra N; Rastogi M; Thakur R
    Indian J Dermatol Venereol Leprol; 2014; 80(2):115-21. PubMed ID: 24685846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sales and science: changing patterns of pharmaceutical and medical device advertising in peer reviewed urology publications, 1975-2000.
    Nelson CP; Bloom DA
    J Urol; 2001 Dec; 166(6):2317-20. PubMed ID: 11696770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The advertising message of drugs advertisements in Spanish medical journals].
    Riera EJ; de la Fuente DO; Rodrígueza RM
    Gac Sanit; 2007; 21(5):371-7. PubMed ID: 17916300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal.
    Lexchin J; Holbrook A
    CMAJ; 1994 Jul; 151(1):47-54. PubMed ID: 8004560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Misleading advertising for antidepressants in Sweden: a failure of pharmaceutical industry self-regulation.
    Zetterqvist AV; Mulinari S
    PLoS One; 2013; 8(5):e62609. PubMed ID: 23650519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ["New wonder pill!"--what do Norwegian newspapers write].
    Høye S; Hjortdahl P
    Tidsskr Nor Laegeforen; 2002 Jun; 122(17):1671-6. PubMed ID: 12555610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug advertising as communication between the pharmaceutical industry and the physician: advertisements for psychotropic drugs in the Dutch medical journal, Nederlands Tijdschrift voor Geneeskunde, 1900-1940].
    van der Hoogte AR; Pieters T
    Studium (Rotterdam); 2010; 3(4):139-54. PubMed ID: 22586821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The accuracy of drug information from pharmaceutical sales representatives.
    Ziegler MG; Lew P; Singer BC
    JAMA; 1995 Apr; 273(16):1296-8. PubMed ID: 7715044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advertising in dermatology journals: journals' and journal editors' policies, practices, and attitudes.
    Bartus CL; Katz KA
    J Am Acad Dermatol; 2006 Jul; 55(1):116-22. PubMed ID: 16781302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan.
    Rohra DK; Gilani AH; Memon IK; Perven G; Khan MT; Zafar H; Kumar R
    J Pharm Pharm Sci; 2006; 9(1):50-9. PubMed ID: 16849008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dutch Journal of Medicine stops with advertisements from pharmaceutical companies].
    Olde Rikkert MGM; Cleyndert ELG
    Ned Tijdschr Geneeskd; 2021 Dec; 166():. PubMed ID: 35138750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The scientific information that the pharmaceutical industry provides to family doctors].
    Rivera Casares F; Richart Rufino MJ; Navas Cutanda J; Rodríguez Górriz E; Gómez Moruno C; Gómez García B
    Aten Primaria; 2005 Jun; 36(1):14-8. PubMed ID: 15946610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In which journals will pediatricians find the best evidence for clinical practice?
    Birken CS; Parkin PC
    Pediatrics; 1999 May; 103(5 Pt 1):941-7. PubMed ID: 10224169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of written advertising material distributed through community pharmacies in Riyadh, Saudi Arabia.
    Al-Aqeel SA; Al-Sabhan JF; Sultan NY
    Pharm Pract (Granada); 2013 Jul; 11(3):138-43. PubMed ID: 24223078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.